Entry is open to students in the 10th and 11th grades living in the US and the District of Columbia who have a strong scientific interest, especially in cancer research and care. Special emphasis will be focused on students from economically disadvantaged high schools. Entries will be accepted from September 1 through November 1, 2015 at 11:59pm ET. In addition to the mentoring opportunity, students will also be awarded a Google Chrome Notebook to enhance their studies and to extend the reach of mentors to students living in rural and suburban communities, a $1,500 stipend for expenses, and the opportunity to continue the mentoring program, through high school, to further their academic pursuits. Students, including those who receive Emperor Science Awards, will be eligible to reapply in subsequent years.
Students, teachers, guidance counselors and parents can visit The Emperor Science Award website (www.EmperorScienceAward.com) to learn more about the program and to apply. The webpage contains an overview of the program and associated resources for students. To enter, students will be asked to submit a 750 maximum word essay on the following topic:
“Cancer has been referred to as The Emperor of All Maladies and millions of people around the world are looking for a cure. In America, more than 1600 people die each day. Tell us why scientific research is so important in helping to find a cure for cancer. And if you could be a scientific researcher, what would you study and why?”
Essays will be judged on sincerity, creativity, clarity and persuasiveness.
Winning students will be connected with science mentors from a host of high-profile medical research centers, including more than 100 SU2C-affiliated institutions, universities and industry leaders in cancer diagnosis and treatment. Among the renowned researchers who have committed to serving as mentors are:
- Siddhartha Mukherjee, M.D., Ph.D. (Author, The Emperor of All Maladies: A Biography of Cancer);
- Otis W. Brawley, M.D., F.A.C.P. (Chief Medical Officer, American Cancer Society)
- Researchers from leading institutions, including University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center and Stony Brook University Cancer Center
- Researchers from leading industry organizations, including Genentech, Bristol-Myers Squibb, Novartis and Siemens Corporation